| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 30 Sep 2026 | 5 Sep 2026 |
| We wish to inform that pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) as amended from time to time, we are hereby submitting the Notice of 13th Annual General Meeting of the Company scheduled to be held on Wednesday, September 30, 2026. Proceeding of 43rd Annual general Meeting of members of Skybiotech Healthcare Limited (As per BSE Announcement dated on: 30.09.2026). Submission of Scrutinizer Report for the 43rd Annual General Meeting of Company held on 30th September, 2026 (As per BSE announcement dated on : 01.10.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.